Dr. Julie Brahmer from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins shares details about the recent FDA approval of nivolumab (Opdivo) for advanced non-small cell lung cancer. She explains how this impacts the treatment of lung cancer.
First in this podcast series, Dr. Brian Rini shares his perspective on current and new approaches to kidney cancer treatment.
Get highlights of four studies that address ways to improve the care of men with prostate cancer. Results include the identification of a potential risk factor, better ways to select the best treatment option, and new insight into the debate over prostate-specific antigen (PSA) screening.
Dr. Neal Meropol and his colleagues created the video-based PRE-ACT program to answer questions and concerns patients have about participating in clinical trials. This tool is now available on Cancer.Net.
In this podcast, Dr. Smitha Krishnamurthi shares highlights of a new study about the connection between Vitamin D levels and colorectal cancer treatment.
Research presented this weekend will highlight three potential new approaches to the treatment of colorectal cancer.
In these two podcasts, Dr. Sundar Jagannath and Dr. Hope Rugo share the latest highlights in myeloma and breast cancer research.
In this podcast, Jeffrey S. Weber, MD, PhD, explains the recent ASCO statement on phase I clinical trials and why these studies are important treatment options to discuss with your doctor.
According to a new Journal of Clinical Oncology study, physical inactivity and TV watching are linked to higher mortality risks for colorectal cancer survivors. However, you don't have to miss your favorite shows to become more active.
In this podcast, Dr. Howard Sandler explains the recent ASCO guideline endorsement about radiation therapy after prostate surgery.